---
category: listing
circular_id: 4cb3f65fe82c8d67
date: '2025-12-04'
description: BSE announces listing of 8,124,698 equity shares of Ind-Swift Laboratories
  Limited pursuant to scheme of amalgamation with Ind-Swift Limited, effective December
  5, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={20BBB38F-4DBA-4435-BD7A-6CA01DC00159}&noticeno=20251204-43&dt=12/04/2025&icount=43&totcount=58&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Medium importance as it involves listing of significant number of shares
  (8.12 million) from amalgamation scheme, which may impact stock liquidity and trading
  volumes but represents corporate restructuring rather than new capital raising.
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251204-43&attachedId=
processing:
  attempts: 1
  content_hash: 8df9f1519ba00cbb
  processed_at: '2025-12-04T21:24:55.747587'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-04T13:10:11+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={20BBB38F-4DBA-4435-BD7A-6CA01DC00159}&noticeno=20251204-43&dt=12/04/2025&icount=43&totcount=58&flag=0
severity: medium
source: bse
stocks:
- INDSWFTLAB
tags:
- listing
- amalgamation
- equity-shares
- scheme-of-arrangement
- ind-swift-laboratories
- merger
title: Listing of new securities of Ind-Swift Laboratories Limited
---

## Summary

BSE has announced the listing of 8,124,698 new equity shares of Ind-Swift Laboratories Limited (Scrip Code: 532305) pursuant to a scheme of amalgamation between Ind-Swift Limited (Transferor Company) and Ind-Swift Laboratories Limited (Transferee Company). The new securities will be available for trading from December 5, 2025.

## Key Points

- 8,124,698 equity shares of Rs. 10/- each face value being listed
- Shares issued under Scheme of Amalgamation of Ind-Swift Limited with Ind-Swift Laboratories Limited
- Amalgamation approved under Sections 230-232 of the Companies Act, 2013
- ISIN: INE915B01019
- Distinctive Numbers: 73486861 to 81611558
- Date of allotment: August 25, 2025
- Trading effective date: December 5, 2025

## Regulatory Changes

No regulatory changes. This is a standard listing procedure following completion of a court-approved scheme of amalgamation under the Companies Act, 2013.

## Compliance Requirements

- Trading members must note the listing of new securities for Ind-Swift Laboratories Limited (Scrip Code: 532305)
- The new shares will be tradable under the existing ISIN INE915B01019
- Trading members should update their systems to reflect the increased share capital

## Important Dates

- **Notice Date**: December 4, 2025
- **Date of Allotment**: August 25, 2025
- **Trading Commencement Date**: December 5, 2025 (Friday)

## Impact Assessment

**Market Impact**: Medium. The listing of approximately 8.12 million shares represents a significant addition to the tradable float of Ind-Swift Laboratories Limited. This may lead to increased trading volumes and potentially impact liquidity. Investors should note that these shares arise from a merger and not from fresh capital raising.

**Shareholding Impact**: The amalgamation consolidates Ind-Swift Limited into Ind-Swift Laboratories Limited, with shareholders of the transferor company receiving shares in the transferee company. This corporate restructuring may lead to changes in shareholding patterns.

**Operational Impact**: This is part of a corporate restructuring exercise to consolidate operations and streamline the corporate structure of the Ind-Swift group of companies.